Marksans Pharma takes a step further to reach its goal of Rs 2,000 crore in revenue Marksans Pharma takes a step further to reach its goal of Rs 2,000 crore in revenue This deal will enable Marksans to use the front-end sales & marketing infrastructure of Access Healthcare DSIJ Intelligence-3 / Monday, April 25, 2022 / Article rating: 5.0 The stock has delivered a strong performance on an MTD basis as it went up by over 20 per cent.